CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection
about
CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-CellsPD1-Expressing T Cell Subsets Modify the Rejection Risk in Renal Transplant PatientsUnusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders.Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.Memory T cells in organ transplantation: progress and challenges.Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells.Increased Pretransplant Frequency of CD28+ CD4+ TEM Predicts Belatacept-Resistant Rejection in Human Renal Transplant Recipients.Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?Should belatacept be the centrepiece of renal transplantation?T Cells Going Innate.The effect of chronic kidney disease on T cell alloimmunity.Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model.Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept.Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice.CD4+ CD28-Negative Cells: Armed and Dangerous.Immunological Characteristics of a Patient With Belatacept-Resistant Acute Rejection After Face Transplantation.The Role of Costimulation Blockade in Solid Organ and Islet Xenotransplantation.Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience.T-Cell Composition of the Lymph Node Is Associated with the Risk for Early Rejection after Renal Transplantation.IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection.Co-inhibitory profile and cytotoxicity of CD57+ PD-1- T cells in end-stage renal disease patients.Benefits and limitations of belatacept in 4 hand-transplanted patients.Blood biomarkers of kidney transplant rejection, an endless search?T Cell Subsets Predicting Belatacept-Resistant Rejection: Finding the Root Where the Trouble Starts.T Cell Repertoire Maturation Induced by Persistent and Latent Viral Infection Is Insufficient to Induce Costimulation Blockade Resistant Organ Allograft Rejection in Mice.
P2860
Q33631095-2D415329-2605-4A80-A8B9-F18A9FD2102EQ35937227-BB882BB0-7FB6-4FEB-9285-7001EB146E5BQ36786393-F2173575-CB26-4D86-A877-ABDB8E559878Q37541433-808D9253-7804-4430-9AE2-5217B74B3548Q38681685-7652FC97-4B31-483D-8107-D67DFD89E16BQ38753494-843B665C-BB45-4BEC-B526-146883FACFA9Q38787322-A4214BD6-3854-405D-A9EB-48B2B933F9E6Q38787359-9AFB9779-F3E8-4E83-A546-19D55DC6A08FQ38804454-FF286F7E-4B54-47E0-949D-9ECAE9674D01Q38862002-29CD8C55-47D2-4C74-8E44-40AD4B9074EBQ38893279-D60797AF-2C5E-4D27-A317-BB6F9647C60CQ39031609-AA7D8D5A-A330-457D-9226-B1A488D8C6A6Q39152748-82562DA5-F397-484F-B0B5-B8F1C08D9F94Q40181170-0637D00D-4F9F-4C3F-8665-29C02F65258DQ40198753-21FE04EB-3CF6-4B02-9866-923269FF4994Q42362413-F016695A-2B83-4D32-A106-5022D34233F1Q42393633-96FE26CA-D9F5-4D67-A5CB-A40997EB85C8Q42725698-961E1193-1C0C-4442-AD1F-5BB8BCD8BB13Q44770974-8DF30CD5-012B-42C0-8DB1-83060525BEF9Q45964615-AC25B9F4-8DC3-4327-A557-EBCD71764F9AQ47120971-208FB0D8-819E-41FA-93EC-C5EC646DEE8AQ47404836-777590A5-5584-488D-B90B-F246537BC380Q47804698-44E1679D-E85B-4FC7-924F-C51DC359CBF9Q48029608-0108535A-F9C8-4C5D-97D3-CFD27917F515Q48785899-09A54F5F-0AFC-4874-B475-C5581BAAA2ADQ50945312-AB37DDBB-F1B5-43E8-802D-C9155E7E6096Q55436826-80B87C89-8222-4CEA-8CBB-F432119985B7
P2860
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection
@en
type
label
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection
@en
prefLabel
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection
@en
P2093
P2860
P356
P1476
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection
@en
P2093
A Durrbach
J Cheeseman
J Espinosa
L Stempora
R Townsend
P2860
P304
P356
10.1111/AJT.13613
P407
P577
2016-01-14T00:00:00Z